News

Sam Borgert to Join Antibiotic Adjuvant as a Pharmacist Advisor

Sam Borgert to Join Antibiotic Adjuvant as a Pharmacist Advisor 150 150 adjuvant-admin

Gainesville, FL – December 1st, 2018 – Antibiotic Adjuvant announced today that Sam Borgert will join the company as a Pharmacist Consultant. Sam is a clinical pharmacist in infectious diseases and antibiotic stewardship. He has a broad pharmacy background including patient care, pharmacy management, consulting, research & teaching experience. Sam is coming onboard after retiring as a Clinical Pharmacist for UF Health.

Sam Borgert to join Antibiotic Adjuvant

“We are extremely excited about Sam joining our team” says Guy La Torre, CEO of Antibiotic Adjuvant. “Sam has unprecedented experience on antibiotic stewardship in different settings and possess great qualifications to enhance our clinical team” added LaTorre.

Sam enhances Antibiotic Adjuvant’s clinical team by bringing the pharmacist voice and experience into the mix of nurses and infectious disease specialists who currently make up the clinical team.

About Antibiotic Adjuvant: Antibiotic Adjuvant is a digital health startup addressing the problem of antibiotic misuse to reduce antibiotic resistance, improve patient outcomes, and reduce the patient cost of care. Our first product, SmartSteward™, optimizes antibiotic use on skilled nursing facilities. We have 3 active pilots and are developing our platform with our experienced team and selected nursing home staff including physicians, nurses and pharmacists.

Antibiotic Adjuvant Recognized as a Rising Startup by StartupGNV

Antibiotic Adjuvant Recognized as a Rising Startup by StartupGNV 1320 400 adjuvant-admin

Gainesville, FL – November 29, 2018 – Antibiotic Adjuvant was recognized by the Gainesville entrepreneurial community as a rising star during the inaugural CelebrateGNV. Other companies recognized include BehaviorMe, aha Pure Foods, Preview, Brio, and Charlotte.ai. CelebrateGNV was organized by StartupGNV to showcase the thriving community and startup scene in Gainesville.

“We are honored to be acknowledge by our peers as a rising star in Gainesville” said Guy LaTorre, CEO of Antibiotic Adjuvant. “Gainesville’s startup scene is growing and we are proud to be part of this community”. LaTorre added.

The Gainesville Area Innovation Network rebranded as StartupGNV earlier this year to underscore the focus on helping startups form, fund, and grow in the metro Gainesville area. StartupGNV organized two Startup Weekend Gainesville and announced the creation of a committee to fulfil the spirit of the mission of the Gainesville Tech Association who will join the board of StartupGNV in 2019.

About StartupGNV: StartupGNV is a 501(c)3 that helps entrepreneurs form, fund, and grow their startups.

BIOPitch and Investor Participation

BIOPitch and Investor Participation 150 150 adjuvant-admin

Fort Lauderdale – October 8, 2018 – On behalf of BioFlorida, an investor committee has selected 16 seed and early-stage life science companies to compete during BioPitch at the BioFlorida Conference taking place October 14-16 at The Westin Fort Lauderdale Beach Resort in Fort Lauderdale, FL.

The companies will present to investors during a closed-door session on the afternoon of Monday, October 15. Four selected finalists will present during the Tuesday morning session to a panel of investors, and the winner will be announced at the close of the session.

BioPitch Committee Co-Chair: Jane E. Teague, Institute for Commercialization of Florida Technology
BioPitch Committee Co-Chair: Valerie McDevitt, JD, University of South Florida

CONGRATULATIONS TO OUR SELECTED COMPANIES!

Antibiotic Adjuvant (Gainesville)

Aventusoft (Boca Raton)

Celigenex (Fort Lauderdale)

Dalent Medical (Coral Gables)

HealthSteps (Gainesville)

KynderMed (Tallahassee)

M:14;22-33 (Gainesville)

Moterum Technologies (Seneca, SC)

Nutent Therapeutics (Boca Raton)

RashEndZ (St. Petersburg)

Resility Health (Jacksonville)

Simple Foods Collaborative Company

(Hallandale Beach)

STAT3 Therapeutics (Coral Springs)

Stuart Therapeutics (Stuart)

ThNA BioSciences (TAMPA)

Vestion (Miami)

INVESTORS PARTICIPATING IN BIOPITCH

  • Todd Andersen-Davis | Florida Technology Seed Capital Fund  
  • Marc Blumenthal | Florida Funders
  • Nathan Cali | NOBLE Life Science Partners
  • Tom Cardy | New World Angels
  • Tim Cartwright | Tamiami Angel Fund
  • Kathy Chiu | FAN Fund  
  • Tom Gardner | Bridge Angel Investors
  • Steve Glover | Asclepius Lifesciences / Variant
  • Kunal Jain | TiE Tampabay Angel Fund I L.P.
  • Brian M. Koslow | DWBK Partners LLC  
  • Orin Levy | Angel Investor
  • Peter Livingston | Angel Investor
  • Ben Scruggs | Hatteras Venture Partners
  • Jackson Streeter, MD | Institute for Commercialization of Florida Technology
  • John Tullis | Tullis Funds
  • Harry Venezia, Jr. | Healthcare Capital Advisors

MENTORING FOR OUR BIOPITCH COMPANIES PROVIDED BY

Final Four Announced for the $50,000 Cade Prize

Final Four Announced for the $50,000 Cade Prize 150 150 adjuvant-admin

Contact: Ashley Bryant
Phone: (352) 371-8001
Cell: (352) 870-9809
Email: abryant@cademuseum.org

GAINESVILLE, FL – The Cade Museum for Creativity & Invention is pleased to announce the Final Four contestants in the 9th Annual $50,000 Cade Museum Prize for Innovation. Named after Dr. J. Robert Cade, who led the team that invented Gatorade at the University of Florida in 1965, the Prize is an annual competition for early-stage inventors and entrepreneurs. The Cade Prize serves to identify, recognize, and celebrate inventive minds and innovation in the state of Florida. Thank you to our Presenting Sponsor, Cox Communications. This year the Cade Museum received over 100 entries from around the state. The Final Four contestants are:

  • Antibiotic Adjuvant | Gainesville, FL  
  • InitWeather | Orlando, FL  
  • Soilcea | Tampa, FL  
  • Standing Wave Reformers | Gainesville, FL

In past years, the Cade Prize awarded a single applicant. This year, cash prizes will be awarded to the top four rankings. The winner of the Final Four will be announced at the Cade Museum’s annual Inventivity Bash on September 29th from 6 PM to 10 PM. First place will be awarded $25,000, second place $15,000, third place $7,500, and fourth place $2,500. Funding for the prize is provided by the Community Foundation of North Central Florida. The Cade Museum’s Inventivity Bash is an annual event that celebrates ideas and innovations that have the potential to transform lives and communities. This year’s iBash theme is Illuminating Invention. The evening’s program has been designed for exploration whether you are a scientist, inventor, or have an interest in both. There will be table presentations featuring the Final Four teams, demonstrations, hands-on interactives, a scavenger hunt, and the awarding of the Cade Prize.

Thank you to all our sponsors for your support and contributions! Cox Communications, Inc. | Advantage Publishing Inc. | Oelrich Construction Inc. | Saliwanchik, Lloyd & Eisenschenk |Info Tech, Inc. | Capital City Bank | Feathr

In 2004, Dr. James Robert Cade and his family established the Cade Museum Foundation to design and build a museum in Gainesville, Florida. The mission of the museum is to transform communities by inspiring and equipping future inventors, entrepreneurs, and visionaries. Dr. Cade, a physician at the University of Florida, was best known as the leader of the research team that invented Gatorade in 1965.

For more information on providing financial support or ways to volunteer at the Cade Museum, please visit our website to purchase iBash tickets or memberships.

Guy LaTorre to Join Antibiotic Adjuvant as Chief Executive Officer

Guy LaTorre to Join Antibiotic Adjuvant as Chief Executive Officer 150 150 adjuvant-admin

Gainesville, FL – The Company would like to announce the recent appointment of Mr. Guy LaTorre as Chief Executive Officer. Guy has over 25 years experience in the commercialization of medical devices in the regenerative medicine, oral care and IVD space. Prior to this, Guy has held numerous executive management positions including CEO of Breathtec Biomedical Inc., COO for Armor Dental Corp. and co-founder and Vice President of Business Development at Novamin Technology Inc.
Guy LaTorre
“I am very excited about the direction of the Company, the quality of the team and the important work we are doing to address the overuse and misuse of antibiotics”. LaTorre says about joining the Antibiotic Adjuvant team.

David Flores, the acting CEO, will be the Chief Operating Officer. “We are extremely excited to bring someone with the experience that Guy has to our leadership team. It shows the potential that our product has and how we are evolving as a company.” Flores says about the news.

About Antibiotic Adjuvant: Antibiotic Adjuvant is a digital health startup addressing the problem of antibiotic misuse to reduce antibiotic resistance, improve patient outcomes, and reduce the patient cost of care. Our first product, SmartSteward, optimizes antibiotic use on skilled nursing facilities. We have 3 active pilots and are developing our platform with our experienced team and selected nursing home staff including physicians, nurses and pharmacists.

Antibiotic Adjuvant Selected as Part of the Sweet 16 for the Cade Prize

Antibiotic Adjuvant Selected as Part of the Sweet 16 for the Cade Prize 1280 914 adjuvant-admin

Gainesville, FL – Antibiotic Adjuvant has been selected as a finalist for the Cade Prize to be held September 29, 2018. The Cade Prize serves to identify, recognize, and celebrate inventive minds and innovation in the state of Florida. Since its launch in 2010, the Cade Prize competition has drawn applications from hundreds of creative thinkers and cutting-edge ventures in IT, healthcare, biomedicine, environmental science, and agriculture, to name a few.

“We are very excited to be among such a distinguished group of startups,” remarks David Flores, CEO of Antibiotic Adjuvant. “After completing IndieBio in April, we have been actively looking for pitching competitions in Florida to build relationships with investors,” mentions Flores about their fundraising efforts and how they see this competition helping their digital health startup.

Out of the 100+ submissions, 16 have been selected to be the Sweet 16. For 2018, cash prizes will be awarded to the top four rankings. The Final Four will be named at the 4th annual Inventivity Bash. First place will be awarded $25,000, second place $15,000, third place $7,500, and fourth place $2,500.

About Antibiotic Adjuvant: Antibiotic Adjuvant is a digital health startup addressing the problem of antibiotic misuse to reduce antibiotic resistance, improve patient outcomes, and reduce the patient cost of care. Our first product, SmartSteward, optimizes antibiotic use on skilled nursing facilities. We have 3 active pilots and are finishing our minimum viable product.

About the Cade Museum: In 2004, Dr. James Robert Cade and his family established the Cade Museum Foundation to design and build a museum in Gainesville, Florida. The mission of the museum is to transform communities by inspiring and equipping future inventors, entrepreneurs, and visionaries. Dr. Cade, a physician at the University of Florida, was best known as the leader of the research team that invented Gatorade in 1965.

Antibiotic Adjuvant Selected as Part of the 4 Finalists During this Year’s SUP-X

Antibiotic Adjuvant Selected as Part of the 4 Finalists During this Year’s SUP-X 150 150 adjuvant-admin

Fort Lauderdale, FL (July 26, 2018) – Antibiotic Adjuvant joined 3 other Florida startups as part of the Startup Competition Pitch Contest during SUP-X, the startup expo.

The startups were judged by Dean Hatton from Las Olas VC, Nelly Farra from NMFarra + Co., Marcia Dawood from Mindshift Capital, Tom Wallace from Florida Funders, and Michael Laskey from FAN Fund. The winner of the competition received $25,000 in cash and prizes.

“SUP-X has been a great way to connect with local angels and investors. Some investors have already expressed interest in having deeper conversations about our technology and how we are using it to lower the abuse and misuse of antibiotics in nursing homes” says David Flores, CEO of Antibiotic Adjuvant. “We are very excited about being part of the top 4 four finalists during this event” added Flores.

SUP-X was presented by the South Florida Technology Alliance and received over 1,000 attendees including startups, angel and VC investors, service providers, accelerators, entrepreneur support organizations and others from two dozen states and half a dozen countries.

To learn more about SUP-X visit: https://www.sup-x.org/

Antibiotic Adjuvant Selected as Part of the Top 20 Companies Presenting During the Florida Early Stage Angel Capital.

Antibiotic Adjuvant Selected as Part of the Top 20 Companies Presenting During the Florida Early Stage Angel Capital. 150 150 adjuvant-admin

Tampa, FL (May 2018) – The Florida Venture Forum and Space Florida selected Antibiotic Adjuvant as part of the Top 20 companies to present during the Early Stage Angel Capital. A total of 19 Florida-based companies and one California-based company from a variety of industry sectors were selected to present before an audience of investors, deal professionals and entrepreneurs.

A panel of judges reviewed each selected company’s presentation and supporting materials. The top companies will receive $25,000 of Space Florida’s and $50,000 Accelerating Innovation Award.

This is the 11th year the Florida Venture Forum has hosted the Early Stage Angel Conference. The 20 presenting companies were selected from a pool of more than 150 applicants by a committee of active Florida venture capitalists and other investors. Space Florida provided the Accelerating Innovation prize money totaling $50,000. To date, Space Florida supported capital accelerators, have attracted nearly $160 million in funding and investments for the participating companies. Past early stage presenters have attracted more than $80 million in funding.

About The Florida Venture Forum: The Florida Venture Forum is Florida’s largest statewide support organization for investors and entrepreneurs, helping emerging Florida companies connect with sources of capital from across the country. The organization provides programs statewide throughout the year in addition to hosting the Florida Venture Capital Conference, the Statewide Collegiate Business Plan Competition and the Early Stage Angel Capital Conference. www.flventure.org.

About Space Florida: Space Florida was created to strengthen Florida’s position as the global leader in aerospace research, investment, exploration and commerce. As Florida’s aerospace and spaceport development authority, we are committed to attracting and expanding the next generation of space industry businesses. With its highly trained workforce, proven infrastructure and unparalleled record of achievement, Florida is the ideal location for aerospace businesses to thrive – and Space Florida is the perfect partner to help them succeed. www.spaceflorida.gov.

Antibiotic Adjuvant to Present at IndieBio Demo Day

Antibiotic Adjuvant to Present at IndieBio Demo Day 150 150 adjuvant-admin

News Release

Antibiotic Adjuvant’s founders David Flores, Luis F Garcia, and Robert Yancey, MD to take the stage at the biotech accelerator’s Demo Day on April 17 in San Francisco.

SAN FRANCISCO, CA, APRIL 11, 2018—Antibiotic Adjuvant will present its software to reduce antibiotic resistance and antibiotic overuse from the stage at IndieBio Demo Day on April 17, 2018. Antibiotic Adjuvant will join thirteen other companies that have completed the accelerator’s fourmonth biotech training program. A full list of the Class 6 companies can be found on the IndieBio website at indiebio.co/introducing-indiebio-class-six/.

Antibiotic Adjuvant uses existing medical history from a patient, and the facility’s ecology information to provide personalized recommendations to the doctor before they make an antibiotic prescription. The data is analyzed to create an antibiotic stewardship program that uses real-time information to make decisions and can adapt to changes in the facility’s microbiome. Then, using machine learning, it can predict resistant infection, complications, and resistance patterns.

“We are extremely proud to speak at Demo Day and share how we can improve patient outcomes and save hospitals and nursing facilities millions of dollars by implementing antibiotic stewardship programs the right way,” said Flores. “We are optimizing the use of antibiotics, lowering antibiotic resistance, and the number of hospital-acquired infections. Having proved the concepts manually, we have now created a scalable software to affect every antibiotic prescription in a health center.”

Since its first class launched in 2015, IndieBio has provided seed funding, mentorship and R&D tools for 81 companies, whose work tackles global challenges including food security, access to life-saving medical treatments and sustainable materials. As the first seed stage biotechnology accelerator, IndieBio is designed to turn scientists into entrepreneurs, providing them with the business and technical skills to build transformative businesses. Previous IndieBio alumni include Memphis Meats, Koniku, SyntheX, Catalog, Ava Winery, and Qidni Labs.

“This class is an incredible example of what can happen when you give scientists the tools to bridge the gap between research and entrepreneurship,” said IndieBio founder Arvind Gupta. “The life sciences are going through a massive period of disruption, changing in new and exciting ways as people begin to think about biology as a true technological field. The fourteen companies presenting at Demo Day next week are tackling some of the most daunting challenges we face today, and we’re excited to see the impact they will have moving forward.”

Media Contact:

David Flores, 305-322-9378, david@a-adjuvant.com

About Company Antibiotic Adjuvant

Antibiotic Adjuvant leverages health data and machine learning to control antibiotic resistance and healthcare associated infections. Their software help facilities improve patient outcomes and saves millions of dollars in compliance cost for Antibiotic Stewardship and Infection Control Program requirements by optimizing antibiotic usage.

http://antibioticadjuvant.com/

About IndieBio

IndieBio (@IndBio) is the world’s leading accelerator for biotech startups. The IndieBio accelerator program uniquely provides founders with a fully equipped lab, world class mentors and significant seed funding to foster the next generation of biotech entrepreneurs. Notable alumni include Memphis Meats, Koniku, SyntheX, Catalog, Ava Winery, and Qidni Labs.